Expert Analysis

States Should Reconsider Forced PBM Divestiture Laws

State legislatures are attempting to enact policies intended to force pharmacy benefit managers to divest from pha... (more story)

Noncompete Laws Show States Focusing On Bans, Healthcare

The first half of 2026 confirms that state legislatures are driving the most consequential changes in noncompete l... (more story)

Where The Justices Aligned In Appellate Authority Ruling

The real story of the U.S. Supreme Court’s recent ruling in T.M. v. University of Maryland Medical System Corp., f... (more story)

Deals & Corporate Governance More

NC Attorney General's Clash With HCA Cleared For Trial

The North Carolina Business Court has cleared a path to trial in the state attorney general's suit accusing HCA Healthcare of letting the quality of care at Mission Hospital in Asheville languish.

Teva Can't 'Literally Whine' Of Being Held To DOJ Admissions

A Pennsylvania federal judge has taken Teva to task for trying to avoid being held to its admissions of price-fixing in a $225 million settlement with the U.S. Department of Justice, ruling that Humana can use... (more story)

Regeneron Says Drug Approval Irrelevant In Antitrust Case

Regeneron told a Delaware federal court the recent regulatory approval of a new cholesterol drug is irrelevant to its case accusing Amgen of bundling Repatha with other medications, as the court mulls an injun... (more story)

Fenwick, Latham Lead Scribe Therapeutics' $129M IPO

Early-stage biotechnology firm Scribe Therapeutics began trading publicly on Friday after raising $129 million in its upsized initial public offering steered by Fenwick & West LLP and Latham & Watkins LLP.

CVS Seeks Toss Of Hospitals' 340B Suits In NY, Mich.

CVS urged New York and Michigan federal courts to toss separate suits brought by hospital operators accusing the health giant of diverting savings from the federal 340B Drug Pricing Program to itself, saying t... (more story)

Texas Lab, Investors To Pay $24M In COVID-19 Testing Scheme

Owners of a Dallas medical testing laboratory and their investors will altogether pay $24 million to resolve allegations that they ran afoul of the False Claims Act by submitting fraudulent claims to Medicare ... (more story)

Digital Health & Technology More

Planned Parenthood Lab's $6.1M Breach Deal Gets Initial OK

A Washington federal judge has preliminarily approved a $6.1 million class action settlement in two challenges to a state-based diagnostics testing service for Planned Parenthood over a 2025 data breach that r... (more story)

Full Fed. Circ. Won't Review Apple's ITC Loss Against Masimo

The full slate of Federal Circuit judges will not reconsider a panel's determination that Apple has infringed Masimo Corp.'s blood oxygen monitor patents in a high-profile case that led to some Apple Watch imp... (more story)

Apple Can't Get Judge To Toss Masimo's $634M Patent Verdict

Apple has lost its bid to dodge a jury's finding that it owes $634 million for infringing a Masimo Corp. patent after a California federal judge rejected the tech giant's challenge to how the court construed a... (more story)

Pa. Hospital Must Face Bulk Of Website Pixel Tracking Row

A Pennsylvania federal judge has mostly refused to toss a putative class action accusing Warren General Hospital of illegally deploying tracking technology that divulged website visitors' private health inform... (more story)

Fed. Circ. Vacates $12.7M Copyright Award Against Gov't

The Federal Circuit on Thursday vacated a $12.7 million copyright award against the federal government over unauthorized copies of software for a project on military health records, holding that the trial judg... (more story)

23andMe Bankruptcy Plan Bars Data Breach Suit In Calif.

A Missouri bankruptcy judge has told attorneys representing California the state can no longer press its data breach lawsuit against the reorganized 23andMe, finding the state court action is barred by the com... (more story)

Policy & Compliance More

Health Plans Ask 2nd Circ. To Revive Celgene Cancer Drug Row

Health plans and pharmacies backed by Cigna are asking the Second Circuit to revive a proposed class action alleging Bristol-Myers Squibb Co. and its Celgene subsidiary fraudulently obtained patents, filed sha... (more story)

Albertsons Can't Nix 14 Years Of Opioid Claims At Wash. Trial

Albertsons and Safeway can't dodge 14 years' worth of claims in Washington state's lawsuit accusing the grocery stores' pharmacies of irresponsibly dispensing prescription opioids and fueling the state's overd... (more story)

O'Reilly Auto Parts Can't Dodge Tobacco Surcharge Suit

O'Reilly Automotive Inc. must face a former employee's lawsuit alleging he was unlawfully charged hundreds of dollars more per year for health insurance because he used tobacco, with a Missouri federal judge r... (more story)

Judge Keeps New Medicaid 'Frailty' Proof Rule In Place

A Massachusetts federal judge late Wednesday declined to block the government from requiring medically frail Medicaid recipients to prove they are significantly impaired to avoid a new requirement that they en... (more story)

Albertsons Pharmacy Work Was 'House Of Cards,' Judge Told

Albertsons pharmacists in Washington state repeatedly warned supervisors that busy workloads and limited staffing were making it difficult to review prescriptions before filling them, a state judge in Seattle ... (more story)

Novo Faces Narrowed Investor Suit Over Obesity Drug Claims

A New Jersey federal judge narrowed a proposed securities class action against Novo Nordisk, preserving claims that it misled investors about the CagriSema obesity drug's tolerability and a flexible protocol u... (more story)